Blood pressure variability and cardiovascular disease: Systematic review and meta-analysis

BMJ (Online)

Volumn 354, Issue , 2016, Pages

  Stevens, Sarah L ^a   Wood, Sally ^a   Koshiaris, Constantinos ^a   Law, Kathryn ^a   Glasziou, Paul ^b   Stevens, Richard J ^a   McManus, Richard J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b BOND UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMBULATORY MONITORING; BLOOD PRESSURE VARIABILITY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; HOME MONITORING; HUMAN; ISCHEMIC HEART DISEASE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CAUSE OF DEATH; META ANALYSIS; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORING, AMBULATORY; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; HUMANS;

EID: 84982133165     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i4098     Document Type: Review

References (80)

1. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2224-60. doi:10.1016/S0140-6736(12)61766-8.
2. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009;338:b1665. doi:10.1136/bmj. b1665.
3. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-13. doi:10.1016/S0140-6736(02)11911-8.
4. Conen D, Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: a systematic review and meta-analysis. J Hypertens 2008;26:1290-9. doi:10.1097/HJH.0b013e3282f97854.
5. Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens 2012;30:449-56. doi:10.1097/HJH.0b013e32834e4aed.
6. Grassi G, Bombelli M, Brambilla G, Trevano FQ, Dell'oro R, Mancia G. Total cardiovascular risk, blood pressure variability and adrenergic overdrive in hypertension: evidence, mechanisms and clinical implications. Curr Hypertens Rep 2012;14:333-8. doi:10.1007/ s11906-012-0273-8.
7. Takahashi O, Glasziou PP, Perera R, Shimbo T, Fukui T. Blood pressure re-screening for healthy adults: what is the best measure and interval? J Hum Hypertens 2012;26:540-6. doi:10.1038/jhh.2011.72.
8. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993;11:1133-7. doi:10.1097/00004872-199310000-00019.
9. Grove JS, Reed DM, Yano K, Hwang LJ. Variability in systolic blood pressure-a risk factor for coronary heart disease? Am J Epidemiol 1997;145:771-6. doi:10.1093/oxfordjournals.aje.a009169.
10. Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010;375:895-905. doi:10.1016/ S0140-6736(10)60308-X.
11. Björklund K, Lind L, Zethelius B, Berglund L, Lithell H. Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men. J Hypertens 2004;22:1691-7. doi:10.1097/00004872-200409000-00012.
12. Gavish B, Ben-Dov IZ, Kark JD, Mekler J, Bursztyn M. The association of a simple blood pressure-independent parameter derived from ambulatory blood pressure variability with short-term mortality. Hypertens Res 2009;32:488-95. doi:10.1038/hr.2009.39.
13. Kikuya M, Hozawa A, Ohokubo T, et al. Prognostic significance of blood pressure and heart rate variabilities: the Ohasama study. Hypertension 2000;36:901-6. doi:10.1161/01.HYP.36.5.901.
14. Kawai T, Ohishi M, Ito N, et al. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens 2013;31:1387-95, discussion 1395. doi:10.1097/HJH.0b013e328360f796.
15. Gao S, Hendrie HC, Wang C, et al. Redefined blood pressure variability measure and its association with mortality in elderly primary care patients. Hypertension 2014;64:45-52. doi:10.1161/HYPERTENSIONAHA.114.03576.
16. Lau K-K, Wong Y-K, Teo K-C, et al. Long-term prognostic implications of visit-to-visit blood pressure variability in patients with ischemic stroke. Am J Hypertens 2014;27:1486-94. doi:10.1093/ajh/hpu070.
17. Lévesque LE, Hanley JA, Kezouh A, Suissa S. Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes. BMJ 2010;340:b5087. doi:10.1136/bmj.b5087.
18. Suchy-Dicey AM, Wallace ER, Mitchell SVE, et al. Blood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health study. Am J Hypertens 2013;26:1210-7. doi:10.1093/ajh/hpt092.
19. Wei Y, Jin Z, Shen G, et al. Effects of intensive antihypertensive treatment on Chinese hypertensive patients older than 70 years. J Clin Hypertens (Greenwich) 2013;15:420-7. doi:10.1111/jch.12094.
20. Pickering TG, Harshfield GA, Kleinert HD, Blank S, Laragh JH. Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA 1982;247:992-6. doi:10.1001/jama.1982.03320320028025.
21. Modesti PA, Morabito M, Bertolozzi I, et al. Weather-related changes in 24-hour blood pressure profile: effects of age and implications for hypertension management. Hypertension 2006;47:155-61. doi:10.1161/01.HYP.0000199192.17126.d4.
22. Lane D, Beevers M, Barnes N, et al. Inter-arm differences in blood pressure: when are they clinically significant? J Hypertens 2002;20: 1089-95. doi:10.1097/00004872-200206000-00019.
23. Linfors EW, Feussner JR, Blessing CL, Starmer CF, Neelon FA, McKee PA. Spurious hypertension in the obese patient. Effect of sphygmomanometer cuff size on prevalence of hypertension. Arch Intern Med 1984;144:1482-5. doi:10.1001/archinte.1984.00350190188032.
24. Diaz KM, Tanner RM, Falzon L, et al. Visit-to-visit variability of blood pressure and cardiovascular disease and all-cause mortality: a systematic review and meta-analysis. Hypertension 2014;64:965-82. doi:10.1161/HYPERTENSIONAHA.114.03903.
25. Tai C, Sun Y, Dai N, et al. Prognostic significance of visit-to-visit systolic blood pressure variability: a meta-analysis of 77, 299 patients. J Clin Hypertens (Greenwich) 2015;17:107-15. doi:10.1111/jch.12484.
26. Stergiou GS, Ntineri A, Kollias A, Ohkubo T, Imai Y, Parati G. Blood pressure variability assessed by home measurements: a systematic review. Hypertens Res 2014;37:565-72. doi:10.1038/hr.2014.2.
27. Manning LS, Rothwell PM, Potter JF, Robinson TG. Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke: Systematic Review. Stroke 2015;46:2482-90. doi:10.1161/STROKEAHA.115.010075.
28. Taylor KS, Heneghan CJ, Stevens RJ, Adams EC, Nunan D, Ward A. Heterogeneity of prognostic studies of 24-hour blood pressure variability: systematic review and meta-analysis. PLoS One 2015;10:e0126375. doi:10.1371/journal.pone.0126375.
29. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001;38(Suppl 4):S11-7. doi:10.1053/ajkd.2001.28090.
30. Inrig JK. Intradialytic hypertension: a less-recognized cardiovascular complication of hemodialysis. Am J Kidney Dis 2010;55:580-9. doi:10.1053/j.ajkd.2009.08.013.
31. Inrig JK, Oddone EZ, Hasselblad V, et al. Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney Int 2007;71:454-61. doi:10.1038/sj.ki.5002077.
32. Inrig JK, Patel UD, Toto RD, Szczech LA. Association of blood pressure increases during hemodialysis with 2-year mortality in incident hemodialysis patients: a secondary analysis of the Dialysis Morbidity and Mortality Wave 2 Study. Am J Kidney Dis 2009;54:881-90. doi:10.1053/j.ajkd.2009.05.012.
33. National Institute for Health and Care Excellence. Hypertension: Clinical management of primary hypertension in adults (NICE CG127). National Institute for Health and Care Excellence, 2011.
34. Bring J. How to standardize regression coefficients. Am Stat 1994; 48:209-13.
35. Hayden JA, van der Windt DA, Cartwright JL, Côté P, Bombardier C. Assessing bias in studies of prognostic factors. Ann Intern Med 2013;158:280-6. doi:10.7326/0003-4819-158-4-201302190-00009.
36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. doi:10.1136/bmj.315.7109.629.
37. Rosenberg MS. The file-drawer problem revisited: a general weighted method for calculating fail-safe numbers in meta-analysis. Evolution 2005;59:464-8. doi:10.1111/j.0014-3820.2005.tb01004.x.
38. Arashi H, Ogawa H, Yamaguchi J, Kawada-Watanabe E, Hagiwara N. Impact of visit-to-visit variability and systolic blood pressure control on subsequent outcomes in hypertensive patients with coronary artery disease (from the HIJ-CREATE substudy). Am J Cardiol 2015;116:236-42. doi:10.1016/j.amjcard.2015.04.011.
39. Blacher J, Safar ME, Ly C, Szabo de Edelenyi F, Hercberg S, Galan P. Blood pressure variability: cardiovascular risk integrator or independent risk factor? J Hum Hypertens 2015;29:122-6. doi:10.1038/jhh.2014.44.
40. Carr MJ, Bao Y, Pan J, Cruickshank K, McNamee R. The predictive ability of blood pressure in elderly trial patients. J Hypertens 2012;30:1725-33. doi:10.1097/HJH.0b013e3283568a73.
41. Eguchi K, Hoshide S, Schwartz JE, Shimada K, Kario K. Visit-to-visit and ambulatory blood pressure variability as predictors of incident cardiovascular events in patients with hypertension. Am J Hypertens 2012;25:962-8. doi:10.1038/ajh.2012.75.
42. Hara A, Thijs L, Asayama K, Jacobs L, Wang JG, Staessen JA. Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the Systolic Hypertension in Europe trial. PLoS One 2014;9:e103169. doi:10.1371/journal.pone.0103169.
43. Hata J, Arima H, Rothwell PM, et al. ADVANCE Collaborative Group. Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial. Circulation 2013;128:1325-34. doi:10.1161/CIRCULATIONAHA.113.002717.
44. Hsieh Y-T, Tu S-T, Cho T-J, Chang SJ, Chen JF, Hsieh MC. Visit-to-visit variability in blood pressure strongly predicts all-cause mortality in patients with type 2 diabetes: a 5·5-year prospective analysis. Eur J Clin Invest 2012;42:245-53. doi:10.1111/j.1365-2362.2011.02574.x.
45. Kostis JB, Sedjro JE, Cabrera J, et al. Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program. J Clin Hypertens (Greenwich) 2014;16:34-40. doi:10.1111/jch.12230.
46. Lau KK, Wong YK, Chan YH, et al. Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases-relationships and comparisons with vascular markers of atherosclerosis. Atherosclerosis 2014;235:230-5. doi:10.1016/j.atherosclerosis.2014.04.015.
47. Mallamaci F, Minutolo R, Leonardis D, et al. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. Kidney Int 2013;84:381-9. doi:10.1038/ki.2013.132.
48. Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability in the European Lacidipine Study on Atherosclerosis: methodological aspects and effects of antihypertensive treatment. J Hypertens 2012;30:1241-51. doi:10.1097/HJH.0b013e32835339ac.
49. McMullan CJ, Bakris GL, Phillips RA, Forman JP. Association of BP variability with mortality among African Americans with CKD. Clin J Am Soc Nephrol 2013;8:731-8. doi:10.2215/CJN.10131012.
50. Muntner P, Whittle J, Lynch AI, et al. Visit-to-Visit Variability of Blood Pressure and Coronary Heart Disease, Stroke, Heart Failure, and Mortality: A Cohort Study. Ann Intern Med 2015;163:329-38. doi:10.7326/M14-2803.
51. Poortvliet RKE, Ford I, Lloyd SM, et al. Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). PLoS One 2012;7:e52438. doi:10.1371/ journal.pone.0052438.
52. Rossignol P, Girerd N, Gregory D, Massaro J, Konstam MA, Zannad F. Increased visit-to-visit blood pressure variability is associated with worse cardiovascular outcomes in low ejection fraction heart failure patients: Insights from the HEAAL study. Int J Cardiol 2015;187:183-9. doi:10.1016/j.ijcard.2015.03.169.
53. Shimbo D, Newman JD, Aragaki AK, et al. Association between annual visit-to-visit blood pressure variability and stroke in postmenopausal women: data from the Women's Health Initiative. Hypertension 2012;60:625-30. doi:10.1161/HYPERTENSIONAHA.112.193094.
54. Yu JM, Kong QY, Schoenhagen P, et al. The prognostic value of long-term visit-to-visit blood pressure variability on stroke in real-world practice: a dynamic cohort study in a large representative sample of Chinese hypertensive population. Int J Cardiol 2014;177:995-1000. doi:10.1016/j.ijcard.2014.09.149.
55. Rakugi H, Ogihara T, Saruta T, et al. COLM Investigators. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens 2015;33:2165-72. doi:10.1097/HJH.0000000000000668.
56. Asayama K, Kikuya M, Schutte R, et al. Home blood pressure variability as cardiovascular risk factor in the population of Ohasama. Hypertension 2013;61:61-9. doi:10.1161/HYPERTENSIONAHA.111.00138.
57. Hashimoto T, Kikuya M, Ohkubo T, et al. Home blood pressure level, blood pressure variability, smoking, and stroke risk in Japanese men: the Ohasama study. Am J Hypertens 2012;25:883-91. doi:10.1038/ajh.2012.62.
58. Johansson JK, Niiranen TJ, Puukka PJ, Jula AM. Prognostic value of the variability in home-measured blood pressure and heart rate: the Finn-Home Study. Hypertension 2012;59:212-8. doi:10.1161/ HYPERTENSIONAHA.111.178657.
59. Kikuya M, Ohkubo T, Metoki H, et al. Day-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis: the Ohasama study. Hypertension 2008;52:1045-50. doi:10.1161/ HYPERTENSIONAHA.107.104620.
60. Gavish B, Bursztyn M. Blood pressure and heart period variability ratios derived from 24-h ambulatory measurements are predictors of all-cause mortality. J Hypertens 2015;33:491-8, discussion 498. doi:10.1097/HJH.0000000000000459.
61. Hansen TW, Thijs L, Li Y, et al. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension 2010;55:1049-57. doi:10.1161/HYPERTENSIONAHA.109.140798.
62. Mancia G, Bombelli M, Facchetti R, et al. Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study. Hypertension 2007;49:1265-70. doi:10.1161/HYPERTENSIONAHA.107.088708.
63. Mena LJ, Maestre GE, Hansen TW, et al. International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. How many measurements are needed to estimate blood pressure variability without loss of prognostic information? Am J Hypertens 2014;27:46-55. doi:10.1093/ajh/hpt142.
64. Palatini P, Reboldi G, Beilin LJ, et al. Added predictive value of night-time blood pressure variability for cardiovascular events and mortality: the Ambulatory Blood Pressure-International Study. Hypertension 2014;64:487-93. doi:10.1161/HYPERTENSIONAHA.114.03694.
65. Pierdomenico SD, Di Nicola M, Esposito AL, et al. Prognostic value of different indices of blood pressure variability in hypertensive patients. Am J Hypertens 2009;22:842-7. doi:10.1038/ajh.2009.103.
66. Pierdomenico SD, Lapenna D, Di Tommaso R, et al. Blood pressure variability and cardiovascular risk in treated hypertensive patients. Am J Hypertens 2006;19:991-7. doi:10.1016/j.amjhyper.2006.03.009.
67. Pierdomenico SD, Lapenna D, Bucci A, et al. Blood pressure variability and prognosis in uncomplicated mild hypertension. Am Heart J 2005;149:934-8. doi:10.1016/j.ahj.2004.06.029.
68. Pringle E, Phillips C, Thijs L, et al. Syst-Eur investigators. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003;21:2251-7. doi:10.1097/00004872-200312000-00012.
69. Verdecchia P, Angeli F, Gattobigio R, Rapicetta C, Reboldi G. Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension. Am J Hypertens 2007;20:154-61. doi:10.1016/j.amjhyper.2006.07.017.
70. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-54. doi:10.1136/jnnp.54.12.1044.
71. Yudkin PL, Stratton IM. How to deal with regression to the mean in intervention studies. Lancet 1996;347:241-3. doi:10.1016/ S0140-6736(96)90410-9.
72. Parati G, Ochoa JE, Lombardi C, Bilo G. Assessment and management of blood-pressure variability. Nat Rev Cardiol 2013;10:143-55. doi:10.1038/nrcardio.2013.1.
73. Mancia G. Short- and long-term blood pressure variability: present and future. Hypertension 2012;60:512-7. doi:10.1161/ HYPERTENSIONAHA.112.194340.
74. García-García Á, García-Ortiz L, Recio-Rodríguez JI, et al. Relationship of 24-h blood pressure variability with vascular structure and function in hypertensive patients. Blood Press Monit 2013;18:101-6. doi:10.1097/MBP.0b013e32835ebc58.
75. Schillaci G, Bilo G, Pucci G, et al. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012;60:369-77. doi:10.1161/HYPERTENSIONAHA.112.197491.
76. Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011;5:184-92. doi:10.1016/j.jash.2011.03.001.
77. Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012;220:155-9. doi:10.1016/j.atherosclerosis.2011.10.033.
78. Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensivedrug class on interindividual variation in blood pressure and risk of stroke: a systematic review and meta-analysis. Lancet 2010;375:906-15. doi:10.1016/S0140-6736(10)60235-8.
79. Muntner P, Levitan EB, Joyce C, et al. Association between antihypertensive medication adherence and visit-to-visit variability of blood pressure. J Clin Hypertens (Greenwich) 2013;15:112-7. doi:10.1111/jch.12037.
80. Perera R, Clarke P, Farmer A, et al. Optimal strategies for monitoring lipid levels in patients at risk or with cardiovascular disease: a systematic review with statistical and cost-effectiveness modelling. Health Technol Assess 2015;19:1-401. doi:10.3310/hta191000.